U.S. Health Care Spending Reached $4.9 Trillion in 2023
Health sector's share of the economy was similar in 2023 and 2022, but lower than in 2020 and 2021, during height of COVID-19
FDA Approves Ryoncil for Steroid-Refractory Acute Graft-Versus-Host After Allo-HSCT
Ryoncil is first FDA-approved mesenchymal stromal cell therapy for pediatric patients aged 2 months or older
FDA Approves Tryngolza as Adjunct to Diet for Familial Chylomicronemia Syndrome
Tryngolza significantly and substantially reduces triglyceride levels in adults with familial chylomicronemia syndrome
2020 to 2023 Saw Increase in Buprenorphine Dispensing for Teens
Decrease in dispensing seen among young adults; dispensing varied by prescriber specialty and was higher for nurse practitioners
FDA Approves First Generic Liraglutide Once-Daily Injection
Approval is part of FDA effort to prioritize generic approvals for drugs in short supply
Atogepant Superior for Efficacy, Functional Measures in Migraine
Reductions in weekly migraine days seen at weeks 1 to 4 and in monthly migraine days in first four weeks
Study IDs Specific Anaphylactic Triggers Linked to Symptoms, Treatment
Alcohol is more likely associated with nut-induced anaphylaxis when adjusted for age at reaction, male sex
Therapeutic-Dose Anticoagulation Linked to Lower Mortality in COVID-19
Administration of therapeutic- versus prophylactic-dose anticoagulation with heparins linked to lower mortality in patients hospitalized for COVID-19
Upadacitinib Improves Ulcerative Colitis Outcomes at 12 Months
Risk for composite outcome was lower, including lower risks for intravenous steroid use and colectomy, within 12 months in sensitivity analysis
Fish Oil Supplementation Cuts Measure of Prostate Cancer Progression
Findings seen among men enrolled in one year of active surveillance
